Glazer Capital LLC’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Glazer Capital LLC’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-66,710	Closed	-$17K	–	391
2020 Q3	$17K	Hold	66,710	–	–	﹤0.01%	275
2020 Q2	$30K	Hold	66,710	–	–	﹤0.01%	180
2020 Q1	$4K	Hold	66,710	–	–	﹤0.01%	200
2019 Q4	$10K	Hold	66,710	–	–	﹤0.01%	168
2019 Q3	$11K	Hold	66,710	–	–	﹤0.01%	176
2019 Q2	$15K	Buy	66,710 +19,078	+40%	+$3.38K	﹤0.01%	161
2019 Q1	$9K	Sell	47,632 -967	-2%	-$244	﹤0.01%	146
2018 Q4	$19K	Sell	48,599 -1	-0%	–	﹤0.01%	145
2018 Q3	$15K	Hold	48,600	–	–	﹤0.01%	138
2018 Q2	$17K	Sell	48,600 -17,044	-26%	-$7.8K	﹤0.01%	131
2018 Q1	$21K	Sell	65,644 -23,800	-27%	-$9.34K	﹤0.01%	111
2017 Q4	$36K	Buy	+89,444	New	+$34.1K	0.01%	83

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Glazer Capital LLC's NRXPW Position: Q4 2020 in Review

Glazer Capital LLC sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 66,710 shares — an estimated $17K sold.

Glazer Capital LLC first reported a position in NRXPW in Q4 2017 and held it in 12 quarters. The position peaked at $36K in Q4 2017. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

Glazer Capital LLC reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
Glazer Capital LLC sold 66,710 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $17K.
Glazer Capital LLC first reported a position in NRX Pharmaceuticals Warrant in Q4 2017 and held it in 12 quarters.
Glazer Capital LLC's NRX Pharmaceuticals Warrant position peaked at $36K in Q4 2017.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on Glazer Capital LLC's 13F filing for Q4 2020, filed 16 Feb 2021.